Lobbying client

IGM BIOSCIENCES, INC.

Development of engineered IgM antibodies

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
33
Filed by
2
Reported in-house
$1,980,000
Reported by firms
$180,000

These two are not added together. An organisation lobbying for itself reports its own spending, and the firms it retains report what they were paid; the rules ask the first to include the second, but filings do not always do so and a filing gives no way to tell. Each is shown as reported.

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2021 to 2024

Filings

33 filings, newest first.
Filing Filed by Amount
4th Quarter - Termination (No Activity)
4th Quarter 2024
IGM BIOSCIENCES, INC. $10,000 reported
4th Quarter - Termination
4th Quarter 2024
STRATEGIC MARKETING INNOVATIONS $5,000 reported
3rd Quarter - Report
3rd Quarter 2024
IGM BIOSCIENCES, INC. $50,000 reported
3rd Quarter - Report
3rd Quarter 2024
STRATEGIC MARKETING INNOVATIONS $20,000 reported
2nd Quarter - Report
2nd Quarter 2024
IGM BIOSCIENCES, INC. $80,000 reported
2nd Quarter - Amendment (No Activity)
2nd Quarter 2024
STRATEGIC MARKETING INNOVATIONS — reported
2nd Quarter - Reportreplaced
2nd Quarter 2024
STRATEGIC MARKETING INNOVATIONS $15,000 reported
1st Quarter - Report
1st Quarter 2024
IGM BIOSCIENCES, INC. $110,000 reported
1st Quarter - Report
1st Quarter 2024
STRATEGIC MARKETING INNOVATIONS $10,000 reported
4th Quarter - Report
4th Quarter 2023
STRATEGIC MARKETING INNOVATIONS $10,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
IGM BIOSCIENCES, INC. In-house 13 $1,980,000
STRATEGIC MARKETING INNOVATIONS 16 $180,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Medical/Disease Research/Clinical Labs MED 18
Defense DEF 11

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 3932 118th 4
S. 3799 118th 4
S. 2076 118th 4
S. 2076 117th 4
S. 3799 117th 4
H.R. 3932 117th 4
H.R. 7085 118th 3
H.R. 3746 118th 3
H.R. 7024 118th 3
S. 3558 118th 3
H.R. 4421 118th 3
H.R. 5585 117th 3
H.R. 7667 117th 3
S. 4348 117th 3
H.R. 8236 117th 3
S. 3819 117th 3
H.R. 2471 117th 2
H.R. 6833 117th 2
H.R. 2617 118th 1
H.R. 6833 118th 1
H.R. 8236 118th 1
H.R. 2617 117th 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.